Chen Chih-Hsuan, Sun Hsin-Yun, Chien Hsiung-Fei, Lai Hong-Shiee, Chou Nai-Kuan
Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Int J Surg Case Rep. 2014;5(9):637-9. doi: 10.1016/j.ijscr.2014.07.010. Epub 2014 Aug 2.
Opportunistic pathogens can cause severe damage leading to irreversible complications in immune-compromised patients. Here we describe a patient who sustained Blastocystis hominis infection resulting in severe sepsis while on extracorporeal membrane oxygenation (ECMO) support, and the course of treatment taken to treat him.
Our case, a 34-year-old Filipino man, was hospitalized for valvular disease and received valve replacements. ECMO and an intra-aortic balloon pump (IABP) were implemented when the patient developed progressive heart failure after cardiac surgery. Unfortunately, the patient suffered from sepsis with persistent fever and diarrhea, and subsequent examinations indicated the patient was infected by B. hominis. After adequate administration of the antibiotic metronidazole, the patient's symptoms subsided and he was discharged.
Blastocystis hominis is a unicellular protozoa commonly found in the intestinal tract, and the prevalence of B. hominis is 1.5-10% in developed countries and 30-50% in developing countries. The patient needed the support of ECMO and IABP, was immunocompromised to a certain extent; B. hominis can be a harmful opportunistic pathogen for them and lead to severe irreversible complications such as death.
This is the first published article showing that the opportunistic pathogen, B. hominis, can cause severe infection in patients on ECMO support, a result that should be kept in mind when patients come from a place with a high prevalence of B. hominis. The prophylactic medication should be administered routinely when patients live in the region and extracorporeal life-support is used.
机会性病原体可造成严重损害,导致免疫功能低下患者出现不可逆转的并发症。在此,我们描述一名在接受体外膜肺氧合(ECMO)支持治疗期间感染人芽囊原虫并导致严重脓毒症的患者,以及对其采取的治疗过程。
我们的病例是一名34岁的菲律宾男子,因瓣膜病住院并接受了瓣膜置换手术。该患者在心脏手术后出现进行性心力衰竭,遂实施了ECMO和主动脉内球囊反搏(IABP)治疗。不幸的是,患者出现脓毒症,伴有持续发热和腹泻,随后检查表明患者感染了人芽囊原虫。在充分给予抗生素甲硝唑后,患者症状缓解并出院。
人芽囊原虫是一种常见于肠道的单细胞原生动物,在发达国家的感染率为1.5%-10%,在发展中国家为30%-50%。该患者需要ECMO和IABP的支持,在一定程度上免疫功能低下;人芽囊原虫对他们可能是有害的机会性病原体,并可导致严重的不可逆转的并发症,如死亡。
这是第一篇发表的文章,表明机会性病原体人芽囊原虫可在接受ECMO支持的患者中引起严重感染,当患者来自人芽囊原虫感染率高的地区时,应牢记这一结果。当患者居住在该地区并使用体外生命支持时,应常规给予预防性药物治疗。